Posts tagged with ‘patent’

  • Isofol Receives Clinical Use Patent Approval in the United States for Drug Candidate arfolitixorin

    GOTHENBURG, Sweden, June 25, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced approval of a…

    by
  • Patent approved in the United States for Isofol’s drug candidate arfolitixorin

    The patent now approved in the United States expires in 2037 and covers both the Active Pharmaceutical Ingredient (arfolitixorin hemisulfate),…

    by